SLSN
SOLESENCE, INC.
NASDAQ · Consumer Defensive · Household & Personal Products · US
$0.85
−1.50%Year over year
Reported trailing growth
- Revenue
- -14.0%
- EBITDA
- -98.8%
- EBIT
- —
- EPS
- —
- Free cash flow
- +73.2%
- Operating cash flow
- +168.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +18.5%
- EBITDA
- -39.1%
- EBIT
- -69.4%
- Net income
- -57.7%
- EPS
- -57.1%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026